Narges Mohammadtaghvaei
Overview
Explore the profile of Narges Mohammadtaghvaei including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
150
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dinarvand N, Afarin R, Shakerian E, Salehipour Bavarsad S, Mohammadtaghvaei N
Mol Biol Rep
. 2024 Apr;
51(1):541.
PMID: 38642208
Background And Purpose: Liver fibrosis is a reversible liver injury that occurs as a result of many chronic inflammatory diseases and can lead to cirrhosis, which is irreversible and fatal....
2.
Zarezade V, Mohammadtaghvaei N, Rashidi M, Babaahmadi-Rezaei H
Biochem Biophys Res Commun
. 2023 Jun;
671:263-269.
PMID: 37307710
Atherosclerosis, a leading cause of cardiovascular disease, remains a significant global health concern. Tamoxifen and raloxifene, selective estrogen receptor modulators (SERMs), have demonstrated potential cardioprotective effects. However, the underlying molecular...
3.
Tabandeh M, Taha A, Addai Ali H, Razijalali M, Mohammadtaghvaei N
Biomedicines
. 2023 Feb;
11(2).
PMID: 36830883
The alterations of circulating adipocytokines have been reported in thyroid diseases or type 2 diabetes mellitus (T2DM), but such data in T2DM coincident with clinical and subclinical thyroid-dysfunctions are limited,...
4.
Dinarvand N, Cheraghian B, Rahimi Z, Salehipour Bavarsad S, Bavarsad A, Mohammadtaghvaei N
Endocrinol Diabetes Metab
. 2023 Jan;
6(2):e401.
PMID: 36597273
Introduction: Type 2 diabetes mellitus (T2DM) is among the world's top 10 leading causes of death. Additionally, prediabetes is a major risk factor for diabetes. Identifying diabetes co-occurring disorders can...
5.
Jafarirad S, Goodarzi R, Mohammadtaghvaei N, Dastoorpoor M, Alavinejad P
Diabetes Metab Syndr
. 2022 Dec;
17(1):102693.
PMID: 36535123
Background And Aim: Pomegranate as a functional food has various properties and effects on health. The aim of the study was to evaluate the effect of pomegranate extract on serum...
6.
Akbari R, Yaghooti H, Jalali M, Khorsandi L, Mohammadtaghvaei N
BMC Res Notes
. 2022 Oct;
15(1):315.
PMID: 36192786
Objective: Non-alcoholic steatohepatitis (NASH) has become a global medical problem. Currently, there is no approved pharmacologic treatment for this condition. Previous studies have suggested that in the pathogenesis of this...
7.
Shakerian E, Afarin R, Akbari R, Mohammadtaghvaei N
Mol Biol Rep
. 2022 Jan;
49(4):2839-2845.
PMID: 35067813
Background: Hepatic fibrosis is one of the main reasons for mortality in the world. Hepatic stellate cells (HSCs) activate during chronic liver injury, express more Transforming growth factor beta (TGF-β),...
8.
Akbari R, Behdarvand T, Afarin R, Yaghooti H, Jalali M, Mohammadtaghvaei N
BMC Pharmacol Toxicol
. 2021 Oct;
22(1):53.
PMID: 34593018
Background: Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) have become significant global health concerns. In the present study, we aimed to investigate the effects of saroglitazar, a dual...
9.
Goodarzi R, Jafarirad S, Mohammadtaghvaei N, Dastoorpoor M, Alavinejad P
Phytother Res
. 2021 Sep;
35(10):5871-5882.
PMID: 34498307
Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease. The beneficial effects of pomegranate have been shown on insulin resistance and obesity, which are linked to NAFLD...
10.
Taghizadeh Jazdani S, Shahbazian H, Cheraghian B, Jalali M, Mohammadtaghvaei N
BMC Res Notes
. 2021 Aug;
14(1):309.
PMID: 34380558
Objective: Many different genetic variants of proprotein convertase subtilisin kexin 9 (PCSK9) are related to the serum levels of cholesterol and LDL cholesterol (LDL-C). The rs615563 variant of PCSK9 (a...